The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Mid-Year Review 2015 with Immune Pharmaceuticals, Inc. - Developing Therapeutics to Combat Crohn’s Disease and Colitis

SNNLive caught up with Dr. Daniel Teper, CEO of Immune Pharmaceuticals, Inc. (NASDAQ: IMNP) at the Marcum MicroCap Conference 2015 in New York City, NY.

Share With

Thursday, June 25, 2015

   

© 2017 Stock News Now